UD RESEARCH INITIATIVE
BIOPHARMACEUTICALS
ADVANCING MODERN MEDICINES
Biopharmaceutical Innovation
“UD is an emerging leader in the exciting field of biopharmaceutical research. Building on our University’s rich legacy, today’s innovators — our students and faculty — are shaping the front lines of discovery.”
Dennis Assanis
President, University of Delaware
Biopharmaceuticals are revolutionizing medicine. These treatments, which rely on living cells for their production, have been crucial in helping the world gain the upper hand in the battle against COVID-19. Other biopharmaceuticals are highly effective in treating and preventing cancer, diabetes, autoimmune disorders, and bacterial and viral infections. The University of Delaware is pursuing high-tech research to develop these life-saving therapies and advance their manufacturing.
Partnering for progress
The University of Delaware is a major economic engine for Delaware and the entire Northeast Corridor, supporting thousands of jobs far beyond our campus and fueling the region’s competitive edge in the global innovation economy. Discover the possibilities.
Innovation with Impact
2020 Biopharma Market Value
Medicines Currently in Development Around the World
%
Of Medicines in Dev have a Potential to be First-in-Class Treatments
Supports Over 4 Million Jobs Across the Country
Source: PhRMA — 2020 Biopharmaceutical Industry Profile
Biopharmaceutical Discovery, Innovation and Collaboration
The Ammon Pinizzotto Biopharmaceutical Innovation Center is the scientific epicenter for UD’s biopharmaceutical science initiative. The state-of-the-art facility brings together academia, industry and government to create an interdisciplinary hub of discovery, innovation and industrial practices based on a collaborative approach. It is also home to the National Institute for Innovation in Manufacturing Biopharmaceuticals — NIIMBL — leveraging UD’s foundation of impactful partnerships to address the grand challenges of health care, medicine and biopharmaceutical manufacturing.
Related Departments, Centers and Institutes
Department of Chemical and Biomolecular Engineering
Department of Biomedical Engineering
Department of Biological Sciences
Department of Chemistry and Biochemistry
Department of Medical and Molecular Sciences
Delaware Biotechnology Institute
Data Science Institute
Center for Biomanufacturing Science and Technology
National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Take a Virtual Tour
Explore the Ammon Pinizzotto Biopharmaceutical Innovation Center at UD’s STAR Campus by scrolling left, right, top and bottom, to discover what makes this facility so unique.
Biopharma News
The University of Delaware research community is applying its expertise to develop health care solutions using biopharmaceuticals. Check back frequently for updates.
Immerse Delaware Lab Coming to UD
National Institute of Standards and Technology funding includes $83 million for coronavirus
NIIMBL gets $153 Million in New Federal Support
National Institute of Standards and Technology funding includes $83 million for coronavirus
An Honored Inventor
National Academy of Inventors elects UD’s Terry Papoutsakis to 2020 Fellows class
Targeting Drug-Resistant Cancers
UD’s Singh and collaborators find vulnerable stages in stubborn cancer cells
$11 Million from NIH for Research
UD’s COBRE Center to add five investigators with five-year grant extension
New Drug Carrier Systems
UD researchers advance drug delivery systems to treat connective tissue disorders
Learning About a Pandemic While it Happens
UD Prof. Jen Horney teaches epidemiology during the coronavirus pandemic
NIIMBL grants will accelerate COVID-19 response
Testing, training, technology in focus for pandemic response
NIIMBL gets $8.9 million for COVID-19 response
UD-based national institute will address testing, diagnostics, supply chain and vaccine manufacturing
University of Delaware
A Leader in Biopharma
Biopharmaceutical Manufacturing Innovation
Biomedical Research Excellence
World-Class Facilities
UD’s newest research facility is the Ammon Pinizzotto Biopharmaceutical Innovation Center, which opened at STAR Campus in 2020. Within this state-of-the-art facility, you’ll find NIIMBL’s headquarters, the Delaware Biotechnology Institute, UD’s renowned Bio-Imaging Center, laboratories and classrooms.
Partner with us!
We welcome partners who see the value in collaborating with our world-class faculty, providing experiential learning opportunities for our students and employing our graduates. Contact us today!
ASSISTANCE
Compliance Hotline
Phone: (302) 831-2792
Research Administration
Phone: (302) 831-2136
Fax: (302) 831-2828
HOURS OF OPERATION
The University of Delaware Research Office is open from 8 a.m. to 5 p.m. Monday through Friday. The Research Office is closed Saturday and Sunday and observes all University closings and holidays. See the Academic Calendar for more information.